levetiracetam

Generic: levetiracetam

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler novadoz pharmaceuticals llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

levetiracetam 1000 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-097
Product ID 72205-097_600a1657-72c4-4ff5-aa6f-341ac75439c9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214815
Listing Expiration 2026-12-31
Marketing Start 2022-10-07

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205097
Hyphenated Format 72205-097

Supplemental Identifiers

RxCUI
311288 311289 311290 387003
UPC
0372205097308 0372205094925 0372205097605 0372205095922
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA214815 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-097-30)
  • 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-097-60)
source: ndc

Packages (2)

Ingredients (1)

levetiracetam (1000 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "600a1657-72c4-4ff5-aa6f-341ac75439c9", "openfda": {"nui": ["N0000008486"], "upc": ["0372205097308", "0372205094925", "0372205097605", "0372205095922"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003"], "spl_set_id": ["1c4450a1-6c05-4b45-a733-c19b4e861970"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-097-30)", "package_ndc": "72205-097-30", "marketing_start_date": "20241231"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-097-60)", "package_ndc": "72205-097-60", "marketing_start_date": "20221014"}], "brand_name": "Levetiracetam", "product_id": "72205-097_600a1657-72c4-4ff5-aa6f-341ac75439c9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72205-097", "generic_name": "Levetiracetam", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "1000 mg/1"}], "application_number": "ANDA214815", "marketing_category": "ANDA", "marketing_start_date": "20221007", "listing_expiration_date": "20261231"}